Search

The Pooled Employer Plan (PEP) offers expanded retirement savings access for employees in the cannabis and other heavily regulated industries. < Back Würk Partners With Seeds to Dreams Savings Plan, Launches 401(k) Program Jul 17, 2025 staff Cannabis Business Times Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The new Pooled Employer Plan (PEP) expands access to retirement savings for cannabis and other highly regulated, compliance-heavy industries. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Rare Cannabinoid Company (RCC) has introduced a new product in their Mood line designed to relieve stress and uplift spirits, utilizing hemp cannabinoids. The brand is from Hawaii, and the post is about trying their THC+CBC Mood Oil, originally appearing on Leafly. < Back We tried Rare Cannabinoid Company’s THC+CBC Mood Oil Aug 14, 2025 Leafly Staff Leafly Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The latest addition to RCC’s Mood line melts stress & lifts your spirits Rare Cannabinoid Company (RCC) takes your mood as seriously as you do. They’re constantly on the front lines of innovation, creating products using exciting blends of hemp cannabinoids that can help relieve stress and help you find your joy. The Hawaiian brand […] The post We tried Rare Cannabinoid Company’s THC+CBC Mood Oil appeared first on Leafly. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Senator Rand Paul (R-KY) opposes a proposed blanket ban on hemp THC products, arguing that even a small amount of THC is crucial for the health effects of CBD products due to the "entourage effect." He believes such a ban would devastate the hemp industry and has introduced a bill, the Hemp Economic Mobilization Plan (HEMP) Act, to triple the legal THC concentration in hemp. While some colleagues, like Senator Mitch McConnell (R-KY), initially sought a complete ban, McConnell ultimately agreed to pull the language from an agriculture bill after Paul's procedural protest. The Congressional Research Service (CRS) also reported that such legislation would effectively prohibit hemp-derived cannabinoid products. Meanwhile, the alcohol industry is expressing concerns about unregulated hemp products, viewing cannabis as a threat to their market. < Back GOP Senator Says Nobody Will Buy Hemp Products If Strict Federal THC Ban Is Enacted Sep 11, 2025 Kyle Jaeger Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A GOP senator says that if Congress moves forward with a proposal to ban hemp products with any amount of THC, nobody is going to buy the remaining CBD preparations—in large part because “even a little bit” of the intoxicating cannabinoid makes an important difference for health effects. Sen. Rand Paul (R-KY) has made abundantly clear that he’s opposed to a blanket ban on hemp THC products that have been proposed in both chambers this session. And while he’s in favor of increasing regulations for the hemp market, he told LEX 18 in an interview published on Tuesday that an outright prohibition would be disastrous for the industry. Some of his colleagues, including Sen. Mitch McConnell (R-KY), “want a product where, if you were to buy the product, it would have no THC in it—or no measurable THC,” Paul said. “I don’t think anybody will buy those products, because, frankly, the THC– even a little bit of it—is probably what helps to make people more calm, sleep better, or [have] less anxiety,” he said. The senator described what scientists refer to as the entourage effect, where the efficacy of cannabis appears to be enhanced when its cannabinoids work together, rather than being isolated. If legislation is enacted to ban hemp items with any measurable amount of THC, Paul said “we’ll eradicate the hemp industry.” “There’ll be no more hemp industry. It’ll completely eradicate it–all the CBD oil, all the gummies, it’ll be gone,” he said. Paul said last month that he has plans to meet with House lawmakers to “reach a compromise” on an approach to regulate hemp in light of his opposition to the THC proposal. Part of that compromise, he said, is to address concerns he and other stakeholders have about vague language that leaves it up to the U.S. Department of Health and Human Services (HHS) under Secretary Robert F. Kennedy Jr. to determine what constitutes a “quantifiable” amount. Without specifications, the worry it that essentially all consumable cannabinoid products could end up being re-criminalized. Paul successfully prevented the ban from being incorporated into a Senate agriculture spending bill recently passed by the body, with the senator pushing for regulations that he said would promote public safety while preserving the hemp industry that’s proliferated since the crop was federally legalized under the 2018 Farm Bill—a reform that McConnell played a key role in advancing. But while McConnell has contested the idea that the legislation he sponsored would “completely destroy” the market, as Paul and industry stakeholders have insisted, he ultimately agreed to pull the language from the agriculture bill following Paul’s procedural protest. Meanwhile, Paul recently filed a standalone bill that would go in the opposite direction of the hemp ban, proposing to triple the concentration of THC that the crop could legally contain, while addressing multiple other concerns the industry has expressed about federal regulations. The senator introduced the legislation, titled the Hemp Economic Mobilization Plan (HEMP) Act, in June. It mirrors versions he’s sponsored over the last several sessions. Rep. Andy Harris (R-MD), who championed a hemp THC ban in his chamber version of the agriculture spending legislation, told Marijuana Moment that he wasn’t concerned about any potential opposition to the hemp ban in the Senate—and he also disputed reports about the scope of what his legislation would do to the industry. The Congressional Research Service (CRS) released a report in June stating that the legislation would “effectively” prohibit hemp-derived cannabinoid products. Initially it said that such a ban would prevent the sale of CBD as well, but the CRS report was updated to exclude that language for reasons that are unclear. The hemp language is largely consistent with appropriations and agriculture legislation that was introduced, but not ultimately enacted, under the last Congress. Hemp industry stakeholders rallied against that proposal, an earlier version of which was also included in the base bill from the subcommittee last year. It’s virtually identical to a provision of the 2024 Farm Bill that was attached by a separate committee last May via an amendment from Rep. Mary Miller (R-IL), which was also not enacted into law. A leading alcohol industry association, meanwhile, has called on Congress to dial back language in the House spending bill that would ban most consumable hemp products, instead proposing to maintain the legalization of naturally derived cannabinoids from the crop and only prohibit synthetic items. Wine & Spirits Wholesalers of America (WSWA) President and CEO Francis Creighton said in a press release that “proponents and opponents alike have agreed that this language amounts to a ban.” Separately, key GOP congressional lawmakers—including one member who supports marijuana legalization—don’t seem especially concerned about provisions in the bill despite concern from stakeholders that it would put much of the hemp industry in jeopardy by banning most consumable products derived from the plant. *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* Jonathan Miller, general counsel at the U.S. Hemp Roundtable, told congressional lawmakers in April that the market is “begging” for federal regulations around cannabis products. At the hearing, Rep. James Comer (R-KY) also inquired about FDA inaction around regulations, sarcastically asking if it’d require “a gazillion bureaucrats that work from home” to regulate cannabinoids such as CBD. A report from Bloomberg Intelligence (BI) last year called cannabis a “significant threat” to the alcohol industry, citing survey data that suggests more people are using cannabis as a substitute for alcoholic beverages such a beer and wine. Last November, meanwhile, a beer industry trade group put out a statement of guiding principles to address what it called “the proliferation of largely unregulated intoxicating hemp and cannabis products,” warning of risks to consumers and communities resulting from THC consumption. The post GOP Senator Says Nobody Will Buy Hemp Products If Strict Federal THC Ban Is Enacted appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

The cannabis company's board has approved a plan to change its place of incorporation from Canada to the U.S. < Back Verano Proposes to Redomicile Parent Company From British Columbia to Nevada Sep 15, 2025 Cannabis Business Times Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The cannabis company board approved the plan to change its place of incorporation from Canada to the U.S. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

A GOP-controlled congressional committee is set to vote on bills targeting Washington, D.C. policies, including a measure to repeal a local law expanding expungements for marijuana possession. This effort is aimed at "restoring law and order" in D.C., according to Rep. James Comer. The proposed repeal targets the Second Chance Amendment Act, which mandated automatic expungement of certain marijuana possession records. This comes amidst ongoing frustration from advocates and D.C. Delegate Eleanor Holmes Norton regarding congressional interference with the District's cannabis laws, particularly an annual appropriations rider preventing D.C. from using its tax dollars for regulated recreational marijuana sales. Despite this, local officials have expanded the medical marijuana program as a workaround. < Back Congressional GOP Moves To Repeal Marijuana Expungements Law In Washington, D.C. To Fulfill Trump Goal Of ‘Restoring Law And Order’ Sep 8, 2025 Kyle Jaeger Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A GOP-controlled congressional committee is set to vote on a series of bills this week targeting various Washington, D.C. policies, including one measure that would repeal a local law expanding expungements for marijuana possession. The House Oversight Committee, chaired by Rep. James Comer (R-KY), will meet on Wednesday for the markup of 14 bills focused on amending or repealing multiple D.C. laws. “President Trump and House Republicans are committed to restoring law and order in our nation’s capital city,” Comer said in a press release on Friday, noting the president’s push to address perceived inadequacies of local law enforcement. Part of that effort involves the proposed repeal of the Second Chance Amendment Act, a D.C. law passed in 2022 that took effect the next year. Under the law, the District’s judiciary was mandated to automatically expunge marijuana possession records for offenses that took place before D.C. enacted a limited cannabis legalization law in 2014. *Heres’s the key text of the D.C. law that the congressional bill would repeal:* “The Court shall order automatic expungement of all criminal records and court proceedings related only to citations, arrests, charges, or convictions for the commission of a criminal offense that has subsequently been decriminalized, legalized, or held to be unconstitutional by the Court of Appeals for the District of Columbia or the Supreme Court of the United States, or records related only to simple possession for any quantity of marijuana in violation of § 48-904.01(d)(1) before February 15, 2015…” “Under President Trump’s decisive leadership, crime in D.C. is now falling at an unprecedented rate,” Comer said. “The House Oversight Committee stands ready to back the President’s swift action by advancing comprehensive legislative reforms that empower District law enforcement and tackle the escalating juvenile crime crisis head-on.” Advocates have already been frustrated with congressional interference with the District’s cannabis laws—particularly the annual renewal of an appropriations rider from Rep. Andy Harris (R-MD) barring D.C. from using its local tax dollars to implement a system of regulated recreational marijuana sales. While Comer put the new repeal bill on the committee’s agenda for Wednesday, he previously signaled that he’d be open to revisiting the rider. Asked about the possibility of lifting restrictions on D.C. legal cannabis sales, he said in late 2023 “if that’s what Washington D.C. wants, yeah.” Last week, the House Appropriations Committee again advanced the underlying spending bill with the rider kept intact. *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* Rep. Eleanor Holmes Norton (D-DC) has criticized appropriators for putting forward a bill that restricts the District’s autonomy in a number of ways, including the rider to “prohibit the use of funds to commercialize recreational marijuana.” “I am outraged at the number and scope of anti-D.C. home rule riders in the bill released today,” Norton said when the measure cleared subcommittee in July. The congresswoman said in May that she would again again push her colleagues to join her in an effort to remove the cannabis language. “As Congress works on the fiscal year 2026 appropriation bill, I will continue to fight to remove this rider,” she said, while referencing a statement from the White House that called the District’s move to enact local marijuana reform an example of a “failed” policy that “opened the door to disorder.” Trump’s budget request that he released in June similarly contained the Harris rider preventing marijuana sales in D.C., despite voters in the jurisdiction voting to approve legalization in 2014. Former President Joe Biden also repeatedly requested the continuation of the D.C. cannabis rider in budget proposals during his time in office. While D.C. hasn’t been able to use its local funds to implement a system of regulated recreational cannabis sales over the last decade, local officials have taken steps to expand the city’s existing medical marijuana program as a workaround. The post Congressional GOP Moves To Repeal Marijuana Expungements Law In Washington, D.C. To Fulfill Trump Goal Of ‘Restoring Law And Order’ appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Find the best hemp retailers, cultivators, and services in Virginia along with reviews of their top cbd, cbg, and other products. Virginia HEMP Businesses REVIEWS VA FAVORITES GUIDE MAP DISPENSARIES Check out our reviews and ratings of hemp companies across the State of Virginia. These are businesses that have been licensed by the state of Virginia for hemp retail sales and/or cultivation. Their products include hemp flower, CBD, CBG, and more. LEARN MORE VA Hemp Reviews Recent Reviews ALL REVIEWS Grandma's Secret Recipe (Delta-8) Peanut Butter Cookies - The Dispensary RVA I always enjoy having alternatives to vaping and smoking when I'm on the go. I have quite the high tolerance so often I rely on edibles... Terp Interpreter Feb 1, 2023 2 min read Snow 1 - District Hemp Botanicals (VA Recreational) This afternoon I had the grand pleasure of not getting high, but rather, simply relaxing the afternoon away in a state of clear-headed... Ben from Kannabus Sep 15, 2022 3 min read Karma Space Brownie - Flowerz As I set out to review the Karma Space Brownie from Flowerz, I chose to take a different path with this product than my flower reviews.... Ben from Kannabus Aug 23, 2022 3 min read Pink Panther CBD Flower - Flowerz For this CBD flower review, it only seemed fitting to take an afternoon bike ride and enjoy the rare cool air that is unique for August... Ben from Kannabus Aug 12, 2022 3 min read 1 2 VA Favs VA Favorites BY REGION GUIDE MAP REVIEWS Find the list of our favorite hemp stores, lounges, cultivators, and other places to visit across the state of Virginia arranged by Region below. Click an image or company name to learn more or use our Guide Map to help locate the one nearest you. VA Region Select Your Region NORTHERN COASTAL CENTRAL Northern Virginia Northern Virginia Here's a list of our favorite stores, lounges, and other hemp oriented establishments to visit in the Northern Virginia region. Click an image or company name to learn more. Cannabreeze Clyde's Hemp Root Source Deep Roots District Hemp Nature's Cure Coastal VA Coastal Virginia Here's a list of our favorite hemp stores, lounges, and other establishments to visit in the Coastal Virginia region. Select an image or company name to learn more. Hemp House CBD Chesapeake OMG Everything Central VA Central Virginia Here's a list of our favorite stores, lounges, and other hemp establishments to visit in the Central Virginia region. Click an image or company name to learn more. RVA Cannabis THE Dispensary Greener Things VA Rec Guide Map Guide Map REVIEWS LISTINGS Use our Guide Map below to help locate the nearest VA hemp business location that we recommend visiting. Then click for more information.

Members of an Indian tribe in Mississippi approved a referendum to legalize marijuana. The Mississippi Band of Choctaw Indians voted to enact cannabis reform, making the tribe the only source of legal adult-use cannabis in Mississippi. Other tribes are also enacting reform. < Back Mississippi Indian Tribe Approves Marijuana Referendum, Making It First Jurisdiction In The State Poised To Legalize Jun 11, 2025 Kyle Jaeger Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Members of an Indian tribe in Mississippi have approved a referendum to legalize marijuana within its territory. About a month after holding a series of public hearings on the proposal, the Mississippi Band of Choctaw Indians voted to enact the cannabis reform, 55 percent to 45 percent, according to unofficial results posted by the tribe on Tuesday evening. The question that tribal members saw on the ballots read: “Do you support the Tribe developing legislation to decriminalize and regulate the possession, production, and distribution of marijuana on Tribal lands?” With its approval, this makes the tribe the only source of legal adult-use cannabis in Mississippi. “This vote does not automatically authorize or legalize marijuana on Choctaw tribal trust land,” Chief Cyrus Ben said at one of the hearings, according to The Mississippi Free Press. But now that the measure has been approved, the Tribal Council is poised to engage consultants to conduct a feasibility study of legalization, along with research on potential regulations. This is one of the latest examples of increased interest among certain Native American communities to enact reform within their borders—despite federal prohibition and, in cases like Mississippi, state law. More than a fourth of Indigenous communities in the continental United States are now involved with marijuana or hemp programs, according to a map recently published by the Indigenous Cannabis Industry Association (ICIA) in collaboration with the law firm Vicente. In North Carolina, where cannabis remains illegal for medical and adult-use purposes, the Eastern Band of Cherokee Indians approved a legalization referendum in 2023, and sales began last year. It’s drawn attention from congressional lawmakers, including Sen. Thom Tillis (R-NC), who last month asked President Donald Trump’s pick to lead the Drug Enforcement Administration (DEA) to investigate the legal implications of the policy. In Montana, meanwhile, marijuana was legalized statewide through a ballot initiative in 2020, and the legislature recently passed a bill that would allow the governor to enter into compacts with Indian tribes to remove barriers to their participation in the industry. A similar compact agreement system has been in place in Minnesota, where cannabis is also legal for adult use. Last month, Gov. Tim Walz (D) signed the state’s first cannabis compact with the White Earth Band of the Minnesota Chippewa Tribe. It’s believed that in 2020, the Oglala Sioux Tribe, located in South Dakota, became the first tribe to vote to legalize marijuana within a U.S. state where the plant remained illegal. In Wisconsin, indigenous leaders have worked together to craft a campaign called Wisconsin Wellness, which last year held an event at the state Capitol in favor of legalizing medical marijuana. Back in Mississippi, medical cannabis was legalized in 2022, but marijuana remains prohibited for adult use. Hawaii Governor Signals Veto Of Medical Marijuana Expansion Bill, Calling One Provision A ‘Grave Violation Of Privacy’ *Photo courtesy of Mike Latimer.* The post Mississippi Indian Tribe Approves Marijuana Referendum, Making It First Jurisdiction In The State Poised To Legalize appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Certificates of Analysis (COAs) are considered the standard for confirming cannabis product purity and potency, but the current system is flawed. COAs often reveal only what labs are asked to test for, and labs have a bias toward favorable results, leading to a quality crisis with inconsistent ingredients, even if test results appear clean. This lack of visibility threatens brand consistency and consumer trust. The industry is also limited by a lack of mechanism-first research. To raise quality standards, the industry needs broader impurity panels, transparency from labs about what isn't tested, redundant COAs from multiple labs, supplier guarantees for batch consistency, and open collaboration. A COA should be a starting point, not the finish line, for ensuring quality. < Back The Quiet Quality Crisis Behind Cannabis COAs Nov 4, 2025 Shane Johnson, MD MG Magazine Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Most cannabis product developers treat a certificate of analysis (COA) as the gold standard. It’s how they confirm purity, potency, and, in an ideal world, product safety. But behind the clean-looking lab report, something more complicated is unfolding. Across the supply chain, a quiet quality crisis is brewing. Cannabinoid COAs have a history of being selectively framed or outright manipulated. Ingredients that look compliant on paper are inconsistent in practice, and product developers are paying the price in reformulations, delays, and broken consumer trust. COAs reveal only what labs are asked to test for The deeper issues? Most COAs reveal only what the lab was told to look for, and labs have a hidden incentive to give favorable results. Even the cleanest COAs may leave out a slew of factors that can impact consistency, potency, quality, and brand credibility. Some cannabis ingredient producers know exactly how to pass a COA without offering a clean product. By selectively testing one part of a lot, using narrow detection thresholds, or leaving entire classes of impurities untested, a supplier can stay technically compliant even if the material is flawed. This is compounded by the fact that labs that consistently report higher potencies and fewer fails for residual solvents or other contaminants will get more repeat business. Consequently, there is a built-in bias toward reporting favorable results. Even reputable brands can be misled. If a cannabinoid extract contains residual solvents, synthesis byproducts, or unexpected isomers, but those impurities fall below the lab’s reporting limits — or aren’t tested for at all — they’ll never show up on the COA. The result of this lack of visibility is more than just a missed data point. For brands, it’s a threat to consistency and consumer trust. Consistency is the real promise brands must keep Consider Coca-Cola: The formula is designed to deliver the same taste and experience in every can someone cracks open anywhere in the world. The same expectation now exists for cannabinoid products. When ingredients vary from batch to batch — even if the test results come back clean — consistency is undermined, especially for sensory- or effects-driven products like gummies, tinctures, and topicals. Say a hypothetical emerging wellness brand recently launched a functional gummy line using a “THCV-rich” extract. The supplier’s COA promised high purity and verified dosage. But within weeks, customer complaints start rolling in. Some consumers felt no effects at all, while others described outcomes that didn’t align with the product’s promise. After third-party analysis, the brand asks their lab to test for both delta-9 tetrahydrocannabivarin (THCV; the cannabinoid the plant makes) and delta-8 THCV (an isomer that is the signature of degradation and/or suboptimal production techniques). The tests indicate the batch contains mostly delta-8 THCV. Consequently, the brand is forced to pull product off shelves, source new inputs, rerun tests, and re-market the finished product, which costs the team weeks of time, tens of thousands of dollars, and immeasurable reputation damage. And it’s not just consumer-facing brands that feel the impact. Real-world variability has real-world costs One example distributors could face is inconsistency in batch production. Say a distributor purchases a standardized cannabitriol (CBT) isolate after a successful pilot batch was third-party verified. At first, the product works well and is sent to multiple formulator partners. But the second shipment — labeled identically as the original batch — shows obvious differences in color, solubility, and performance. Partners must pause launches, rerun tests, and delay production. The COA was the same for all shipments, but the material clearly was not. In a fast-moving category where timing and consistency are everything, those discrepancies can destroy momentum and brand integrity. Part of the issue is structural. The industry remains underfunded when it comes to mechanism-first research. Instead of asking how cannabinoids work — and how different inputs affect biological pathways — most companies focus on outcome-first claims that validate what’s already being sold. A research gap is limiting progress “Mechanism-first research gives us a blueprint,” said Dr. Tony Ferrari, an analytical chemist with deep expertise in cannabinoid formulation. “Outcome-first research gives us a sales pitch.” This creates a scientific blind spot that affects everything downstream, from testing standards to ingredient consistency. Without fully understanding how minor cannabinoids interact with the body or degrade during processing, we miss clues that could inform better safety protocols and formulation techniques. In most industries, research starts in the lab, but “in cannabis, the reverse happened,” said economist Dr. Ruth Fisher. “People were using it on a massive scale, and then the researchers came in and started looking at what was happening in the real world.” This process reversal may be the industry’s greatest asset. By aggregating real-world data across use cases, outcomes, and product formats, we can uncover patterns and side effects we might never have detected in a traditional laboratory setup. How to raise standards for ingredient quality We can use this asset to raise the bar on cannabinoid quality. The effort will take more than more-accurate COAs. It will require: - Broader impurity panels and updated reference standards. - Transparency from labs about what *isn’t* being tested. - Redundant COAs from at least two different labs for the same batch of material (to demonstrate results are consistent). - Ingredient partners that guarantee consistency batch to batch and ship the actual product represented on the COA. - Open collaboration across brands, labs, and researchers to share real-world observations. COAs should never be the finish line. In a space as complex and rapidly evolving as cannabinoids, a COA should be the starting point, providing a baseline that invites deeper questions, better research, and long-term trust-building. Because what’s not listed on your COA could end up being what costs your brand the most. ------------------------------ FAQ: COA Challenges and Solutions 1. Why isn’t a COA enough to confirm cannabis ingredient purity? Because COAs only show what the lab was instructed to test for — and reporting limits may exclude relevant impurities or isomers. 2. How can a brand verify ingredient consistency across batches? Request redundant COAs from two labs and require suppliers to guarantee batch-to-batch equivalency. 3. What impurities are most commonly missing from standard COA panels? Isomers, synthesis byproducts, residual intermediate compounds, terpene-derived artifacts, and degradation markers. 4. How can labs reduce the incentive bias that leads to inflated potency reports? Transparent methodologies, standardized reference materials, and third-party auditing reduce incentive pressure. ------------------------------ [image: Shane Johnson MD] Shane Johnson, MD, is senior vice president and general manager at BayMedica, which specializes in producing and distributing rare cannabinoids at scale. For the past four years, his work has focused on cannabis and cannabinoid science, and he has developed a strong working knowledge of clinical opportunities in the sector. A Fulbright Scholar, he earned his medical degree from Stanford University School of Medicine. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

The author, Adam Terry, argues that the new federal ban on hemp products containing THC, pushed by Sen. Mitch McConnell, is a critical opportunity for nationwide cannabis legalization by 2026. The ban, which limits THC and redefines "total THC," will abruptly remove access to cannabis for millions of Americans, particularly in red states, creating political leverage. Terry proposes a simple plan: federally de-schedule cannabis, create baseline federal regulations (including age-gating and excise tax), and leave specifics like dosing limits and licensing to the states. He emphasizes the urgency, stating that if action is not taken before 2026, the moment will be lost. < Back The New Federal Hemp Ban Is An Opportunity To Legalize Cannabis Across The Board (Op-Ed) Nov 18, 2025 Marijuana Moment Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link *“Millions of Americans in red states are about to lose access to cannabis, and I intend to ensure that they know it.”* *By Adam Terry, Cantrip* This is the moment—2026 is our last, best chance to actually legalize cannabis in America Last week, Sen. Mitch McConnell (R-KY) pulled off something that many of us in the hemp side of the cannabis industry thought infeasible but long feared: He passed a ban on virtually all hemp products containing THC. After passing the very legislation that underpinned the enormous hemp boom over the last seven years, McConnell managed to force in language to the recent agriculture appropriations bill that limits THC in hemp to 0.4mg of THC, redefines “total THC” to include anything vaguely resembling d9-THC and criminalizes intermediates between plant and product—effectively banning the process that creates CBD isolate. The most surprising result of this? We are going to use this to finally and truly legalize all cannabis nationwide. Hear me out. I have been in the cannabis industry for over a decade, and I was a cannabis legalization activist in the five years before that. I worked on phone banking for Colorado, Washington State and California during their ballot processes in the early 2010s. I campaigned hard for legalization in Massachusetts before we even had a ballot initiative by organizing events and letter campaigns. I believe in cannabis reform as a moral imperative. Each year, cannabis reform has been important work by activists who care about personal freedom and the miscarriage of justice that each arrest for cannabis represented, as well as an important initiative to expand the growing state-legal marijuana industry in America. And each year, major media outlets and most Americans have treated cannabis legalization as a mildly interesting side show, perhaps funny but nowhere near as important as the myriad issues that face our nation today. But one thing changed last week: There has never before been a situation where we have seen access to cannabis given to millions of Americans and then abruptly taken away. 359 days until MILLIONS of Americans lose all access to cannabis. There has never been a riper time to push for comprehensive cannabis reform in America. https://t.co/JPRks6NwC0 — Weed Drinks Guy (@cantripguy) November 18, 2025 The hemp industry has had problems with many bad and potentially dangerous products since its inception. I don’t think anyone can legitimately argue that is not true. We have seen hemp used as an excuse to pass off illegally grown cannabis as legitimate, a proliferation of synthetic cannabinoids that no one has any historical safety data on and an unfortunate market for cannabis infused trademark infringements so frequently touted by lawmakers and regulators when they push for bans. In this way, I applaud Congress for taking action to address synthetic cannabinoids and the myriad terrible products launched into the hemp marketplace. What we have also seen is many states choose to regulate hemp in one form or another. Indeed, 40 states in the U.S. regulate hemp in some capacity or another, and many have strict regulations and taxation—look at Alabama, Georgia, Kentucky, Minnesota and Tennessee as strong examples of states that have chosen to regulate instead of ban these products. Mandatory age gating, batch specific testing, certificate of analysis (COA) transparency, specifying venues of sale, dosing caps and banning synthetic cannabinoids to a very large extent are common themes of these programs. Now, millions of Americans have come to rely on hemp as their access to cannabis both in states where marijuana dispensaries exist and where they don’t. Veterans, seniors, soccer moms and average Americans of all walks of life have gotten used to easy access to full spectrum CBD products to alleviate various wellness issues they have—from sleep benefits all the way up through PTSD. Many have switched from alcohol to THC drinks sold at legitimate outlets like Total Wine & More and even Target as regulations and good governance rolled out across multiple marketplaces. Americans are not huge fans of losing personal freedoms, and seniors and veterans know how to activate politically. In my time in the cannabis industry, I have never seen a cannabis policy that instantly removed access to people across the entire country in the way this sweeping sledge-hammer of a ban has. Never before have so many people been affected in a negative way on this issue all at once. Which brings me to my main thesis: For one year only, legalizing cannabis across the United States is now more possible than ever. As someone who has operated businesses in both the hemp and marijuana industries, I have empathy for the operators who have long seen hemp as an unfair competitor to their industry. While I take issue with their logic in many cases, I do understand the emotional state that it comes from. State-legal programs are overregulated, overtaxed, frequently punitive to operators and in many cases prevent meaningful scaling of a brand or business. One of many examples is in my home state: In Massachusetts it is nearly impossible to even grow cannabis outdoors with the way our regulatory scheme works, forcing most flower sold to be grown indoors and sucking up 10 percent of all commercial electricity in the state for something that was grown outdoors safely for millennia. On the hemp side, thousands of legitimate businesses across the country have flourished by operating above board. People have opened up hemp retailers, many focused on wellness and sourcing quality products with quality ingredients. In states like Kentucky, Minnesota and Tennessee, which have very strict regulatory requirements, people have invested their money and time in building businesses compliant with their local regulatory schemes. Many scrutinize the brands they carry heavily, checking for legitimate COAs (there are ways to spot faked ones), spot testing their own products and focusing on quality full spectrum CBD and THC products over synthetic cannabinoid soup. Farmers have come to grow thousands of acres of hemp to support the nearly $30 billion (by some estimates) hemp industry and invested heavily in that infrastructure. Manufacturers and copackers like Scofflaw Brewing in Georgia, which now touts 80 percent of its business as THC manufacturing, have invested millions in equipment that they can’t suddenly get back. Businesses like mine (a beverage brand called Cantrip), born in dispensaries but finding their true success in liquor and grocery stores, pour over state packaging and testing regulations and spend tens of thousands on various attorneys to ensure we create a product compliant with the maximum number of states. To date, I have not found a way to fit language on my can to sell in every state that permits hemp particularly since in some cases that language contradicts other states’ requirements, forcing me to still produce slightly different labels for different states for some products. Cantrip, like others, has forgone otherwise lucrative opportunities in California and New York in order to respect those states’ choices to ban hemp products even when I vehemently disagree with such mandates. Then there’s the alcohol industry. It may be no surprise to find that liquor retailers and distributors love selling THC beverages—indeed in some cases they have seen sales lifts upwards of 25 percent carrying such products, as opposed to the typical 1 percent lift we see in state-legal dispensaries from beverage products. The big suppliers—the macro brands of beer and spirits—have largely been unhappy with the state of the industry and its competition with alcohol. However, I think they could be convinced, given a way to participate. Alcohol consumption is declining independent of the rise of THC beverages, and a ban on THC isn’t going to stop that. I am certain these companies could be very successful in this space if they saw a pathway to participation without risking their other business. I believe that we can bring these stakeholders together for an historic moment in an upcoming critical election year. I’ve met few folks in the hemp industry who don’t believe that cannabis should be de-scheduled nationwide—pending specifics, of course. Millions of Americans in red states are about to lose access to cannabis, and I intend to ensure that they know it. This is an issue that is going to be palpable as Democrats in tough races like the one for a Georgia Senate seat seek an edge. Red state politicians are going to never want hear the word “cannabis,” again by the time this election is over. We have never had larger awareness or popular support for cannabis, as it is something that has often been reserved for blue states. My proposal is simple, but not easy: we use this moment, where millions of people are about to lose all access to cannabis in states that have zero dispensaries and millions more will lose the easy access they’ve come to enjoy, to once and for all decriminalize, deschedule and regulate cannabis in the U.S. We know that this president loves to do things people think simply can’t be done—why not do something that most Americans already support in poll after poll after poll? It would be a lasting legacy of freedom for Americans. How would we do this? The specific policy proposal is as follows: 1. De-schedule cannabis federally; 2. Create a Code of Federal Regulation chapter with input from industry stakeholders, regulators, and the Department of Health and Human Services that creates baseline guidance for how cannabis and cannabis products need to be treated—this includes age-gating THC products and specifying definitions of intoxicating and non-intoxicating compounds, creating a federal excise tax and reporting system (in spirits, excise tax reporting is actually also your track and trace system) and other general points; 3. Leave questions about milligram limits, licensing, state and local taxes and venue of sale to the states such that Georgia, Kentucky, Minnesota and Tennessee can keep their programs mostly as is. Generally, a low dose product in major venues like grocery and liquor stores and higher dose products like flower, concentrates, and stronger edibles in more specialized dispensaries seems like a good way to go, but each state can have the debate. My proposal is not the only valid solution, but simply a way to start a conversation. It is a policy debate worth having, in the open, and quickly. Should the federal ban go into effect, there can be no question of “state-legal” hemp. There would be no difference between hemp and marijuana at that point; no alcohol retailer or distributor could participate without losing their license and companies like Target would be de-listed from the NYSE and suffer billions in 280E penalties across goods. We need federally legal cannabis; until now, that has been hemp. I propose we make the words marijuana and hemp obsolete and have one unified system for one plant, and I believe we can do this. After 2026, we will lose our shot. On Veterans Day 2026, a deeply painful irony, millions of Americans including veterans will lose access to cannabis products they’ve come to rely on. We will have lost their faith in the professional cannabis community to protect their rights. The issue will fade; Congress will become more jammed than ever with investigations if Democrats win and all legislation will come screeching to a halt. We must take this opportunity now, as one cannabis community, to activate voters in every corner of the U.S. to support descheduling cannabis and creating a viable path to access. To force politicians in tough races to talk about it and support changes. We don’t have much time in 2026 either, as most legislation in an election year tends to conclude before the summer recess given the intensity of the fall campaign. Less than a year, multiple industries, and millions of Americans. We can do this. We will do this. Let’s legalize weed in America. *Adam Terry is the co-founder and CEO of the THC-infused beverage company Cantrip.* The post The New Federal Hemp Ban Is An Opportunity To Legalize Cannabis Across The Board (Op-Ed) appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Michigan lawmakers are considering four bills (HB 5104, 5105, 5106, 5107) aimed at addressing challenges in the state's legal marijuana industry, particularly large illicit grow operations and the inability to sanction former licensees. HB 5105 and 5107, which are tie-barred, would introduce new penalties for cultivating, delivering, and processing black market marijuana and change the legal possession limits for plants and concentrates. HB 5104 and 5106 would allow the Cannabis Regulatory Agency to take disciplinary action against individuals and facilities even after their licenses have expired, or summarily suspend a license if conduct poses a public risk. The legislation is intended to support the licensed industry against bad actors, though some lawmakers expressed concern about increased enforcement and high taxes potentially driving consumers to the black market. < Back Michigan Lawmakers Consider Bills To Change Legal Marijuana Possession Limits And Alter Industry Disciplinary Rules Oct 25, 2025 Marijuana Moment Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link *Michigan has “become, in a lot of ways, sort of a central location for illicit operations, because the penalties for illicit activity are so low here.”* *By Ben Solis, Michigan Advance* Four marijuana-related bills were up for consideration before a House panel on Thursday, with one aiming to upend rules on the legal amount of regulated marijuana a person is allowed to possess, both in plant and concentrate form. Members of the House Regulatory Reform Committee discussed but did not amend or advance House Bill House 5104, Bill 5105, House Bill 5106 and House Bill 5107. Derek Sova, a policy and legislative assistant for the Cannabis Regulatory Agency, told the committee previously that Michigan’s legal marijuana industry faced several challenges, and that two of those big hurdles were large illicit grow operations and the agency’s inability to go after bad actors because their licenses had expired. The series of bills before the committee would address those concerns. House Bill 5105 and House Bill 5107 are sponsored by state Reps. Pauline Wendzel (R-Watervliet) and Mike Hoadley (R-Au Gres), respectively. The bills would in tandem create new penalties for cultivating, delivering and processing black market marijuana, but also change the amount of marijuana a person is legally allowed to possess in plant and concentrate form. The bills are tie-barred together, meaning both would have to jointly clear the Legislature and be signed by the governor to become law. Under Wendzel’s bill, a person would be guilty of a misdemeanor if they possess between 10 and 25 kilograms, or between 50 and 100 plants, or between one and 2.5 kilograms of marijuana concentrate. The penalty would change to up to one year in jail or a $20,000 fine, or both. Keeping between 25 and 125 kilograms, or between 100 and 500 plants, or between 2.5 and 12.5 kilograms of marijuana concentrate would become a felony punishable by two years in prison or a $500,000 fine, or both. *It would also be a felony offense to:* - Keep between 125 and 250 kilograms, or between 500 and 1,000 plants, or between 12.5 and 25 kilograms. That could net a person four years in prison or a $2 million fine or both; and - Keep 250 kilograms or more, or 1,000 plants or more, or 25 kilograms or more of marijuana concentrate. The punishment there would be up to 10 years in prison or a $10 million fine, or both. Sponsored by state Rep. Kristian Grant (D-Grand Rapids), House Bill 5104 would allow the Cannabis Regulatory Agency to sanction a person even if they are no longer a licensee or if they are no longer operating a marijuana facility. At present, the Medical Marihuana Facilities Licensing Act holds that the expiration of a state-issued license terminates the authority of the agency to impose sanctions. The bill from Grant would retain that position but would add that the authority to impose sanctions would continue if there was already a pending action against a former licensee or facility operator. House Bill 5106, sponsored by state Rep. Jerry Neyer (R-Shepherd), would amend the state’s Regulation and Taxation of Marihuana Act to similarly address disciplinary action on recreational licenses. The bill would let the agency summarily suspend a license if the licensee’s conduct poses a risk to the health, safety or welfare of the public. Much like House Bill 5104, Neyer’s legislation would also give the agency authority to take disciplinary action against a person who no longer holds a license or if their license has recently expired. The risks that could lead to license suspension or discipline, as outlined in the bill, include possessing marijuana from a source that cannot be determined, keeping marijuana stashes obtained in violation of the act, obstructing an agency investigation, and failing to provide the agency with required records. Neyer’s bill affects growers, processors, retailers, microbusinesses, safety compliance facilities and secure transporters. State Rep. Emily Dievendorf (D-Lansing) said they were concerned about upticks in enforcement given that some industry folk were previously on the negative end of marijuana enforcement when it was illegal in Michigan. She questioned whether it was right to increase enforcement when the state was actively beginning to tax marijuana sales at a higher rate, which some have warned will ultimately push consumers to the black market. Sova said that the point of the package was to support the licensed industry, as much as possible, especially those following the rules. “That’s the purpose of giving us the greater enforcement authority over the bad actors in the licensed space who are cheating, who are undermining the folks who are trying to do it the right way,” Sova said. “This has been an issue, I believe, in communities where you’ve had a lot of these large illicit outdoor growers. You’re talking sometimes thousands or tens of thousands of plants that, the way the statutes are set up right now, there’s really no disincentive to continue doing that.” Sova added that Michigan has “become, in a lot of ways, sort of a central location for illicit operations, because the penalties for illicit activity are so low here.” State Rep. Joseph Aragona (R-Clinton Township), the committee’s chair, said he agreed with Dievendorf. “The 24 percent tax was difficult,” he said. “We obviously did not want to do in the House, but this could definitely help those legal growers who are going to be paying it, because, if I’m mistaken, the black market won’t be paying that tax.” Sova said that was certainly the intention of the pending legislation. Hoadley also testified along with Iosco County Prosecutor Jim Bacarella and Branch County Prosecutor Zach Stempien, both of whom supported the legislation and expressed concern for those working in the industry. Some of that concern had to deal with the exploitation of migrant workers or foreign nationals, which were issues brought up by the prosecutors during testimony. *This story was first published by Michigan Advance.* *Photo courtesy of Chris Wallis // Side Pocket Images.* The post Michigan Lawmakers Consider Bills To Change Legal Marijuana Possession Limits And Alter Industry Disciplinary Rules appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

The article discusses a collaboration between NBA legend Carmelo Anthony and Skyworld, focusing on discipline, data, and authenticity in their cannabis partnership, as reported by MJBizDaily. < Back Carmelo Anthony and Skyworld build a trust-first cannabis collab Oct 15, 2025 Margaret Jackson MJbizDaily Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A synergistic collaboration between NBA legend Carmelo Anthony and Skyworld prioritizes discipline, data and authenticity. Carmelo Anthony and Skyworld build a trust-first cannabis collab is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

An Indiana bill passed the state Senate Commerce and Technology Committee to align state law with a forthcoming federal ban on intoxicating hemp products and regulate less potent ones, despite arguments from opponents that the measure is premature and could decimate the state's industry. The legislation puts the state's Alcohol and Tobacco Commission (ATC) in charge of regulation, includes business restrictions like banning advertising and operating near schools, and directs most hemp-derived tax revenue to the ATC for administrative efforts and enforcement. < Back Indiana Senate Committee Passes Bill to Align State Hemp Laws With Forthcoming Federal Changes Jan 20, 2026 TG Branfalt Ganjapreneur Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link An Indiana bill to align state law with the forthcoming federal ban on intoxicating hemp products last week passed the state Senate Commerce and Technology Committee, the Indiana Capital Chronicle reports. The legislation would also regulate less potent products allowed under the federal reforms. Cory Harris, representing the American Trade Association for Cannabis and Hemp, told the committee that “it is imperative” that lawmakers act during this session “to harmonize with federal policy” because “failure to do so will mean that Indiana’s policy will be less stringent than federal law, and therefore equate to Indiana being a legal cannabis market.” Justin Swanson, representing the Midwest Hemp Council and 3Chi, a THC product retailer, argued that the proposal is “premature” and that the federal and state laws “will decimate an entire industry in the state.” Swanson noted that “the landscape is still not settled,” as a federal bill sponsored by Indiana Rep. Jim Baird (R) has proposed delaying the ban’s rollout by two years. Additionally, the law includes language that would prevent state law from aligning with federal reclassification of cannabis, as President Donald Trump (R) directed in an executive order last month. State Sen. Aaron Freeman (R), the bill’s sponsor, said he’d like to “eliminate all these things from the face of the planet, period.” “This bill simply says that we would not automatically follow what the federal government does, that we would decide, 150 of us – that we would make that decision, not the federal government for us.” — Freeman during the committee hearing via the Capital Chronicle The Indiana proposal would also put the state’s Alcohol and Tobacco Commission (ATC) in charge of regulating what remains of the industry: implementing permits for manufacturers, distributers, retailers, and carriers. Hemp businesses would also be banned from advertising and operating within 1,000 feet of schools and playgrounds. The bill would direct 70% of hemp-derived tax revenues to ATC administrative efforts, 20% to enforcement, 5% to the state’s 988 suicide and crisis hotline, and 5% to the general fund. The bill heads next to the Appropriations Committee before being considered by the full Senate. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5